Standardized Clinical Evaluation Framework
The primary objective is to synthesize overlapping evaluation constructs from tools like QAMAI, AISPE-Q, and AIPI into a single, standardized, model-agnostic instrument.
MELMA-W aims to prioritize clinical safety over numerical performance, ensuring that high accuracy cannot offset critical medical errors.
Independent Clinician Review: A blinded evaluator reviews an anonymized medical answer
Tier A Safety Screening: The response is screened for binary "Yes/No" safety violations (S1). No numerical score is applied yet.
Tier B Quantitative Rating: Safety-cleared responses are rated across 30 items on a 5-point Likert scale (1=Very Poor, 5=Excellent).
To allow for cross-model comparison, domain scores are calculated as the mean of their sub-items and normalized to a 0–100 scale.
Domain Score = (Mean of Likert Items) × 20
Classification is based on the MELMA-W Clinical Acceptability Framework (MELMA-CAF), which uses a non-compensatory scoring model.
Suitable for clinical support and patient education.
Requires clinical verification by a healthcare professional.
Deemed unsuitable for clinical or patient-facing use.